What changed on 6 August 2026

The UK Global Talent Visa has always had a fast-track route for researchers: if you hold a research grant from an approved funder, endorsement takes two weeks rather than five. Until now, however, your employer also had to be a university, an NHS trust, or an established independent research institute. Commercial companies were excluded.

On 6 August 2026, the government changed this. Over 100 innovative research businesses have been added to the list of approved host organisations, bringing the total to 291 across ten sectors. Researchers working on eligible funded projects at these companies can now apply through the same fast-track pathway that university researchers have always used.

In short: if you work in R&D at one of the approved private companies and you are named on a qualifying research grant, you may now be able to apply for the Global Talent Visa on a fast-track basis, without needing to build a peer review portfolio.

Check if your employer is on the list

The full list of approved host organisations is published on GOV.UK and updated by UKRI. As of August 2026 it includes 291 institutions across universities, NHS trusts, research institutes and the newly added commercial companies.

Among the newly added companies are AstraZeneca, Jaguar Land Rover, Arm, GlaxoSmithKline, Bristol Myers Squibb, IBM, Genomics England, UK Biobank, and a cluster of quantum computing firms including Riverlane, Quantinuum, OQC, Infleqtion, Phasecraft and NuQuantum. Creative industry organisations including the BBC, the British Film Institute, Ffilm Cymru Wales, the Royal Opera House, the Royal Shakespeare Company, Tate and the Victoria and Albert Museum are also on the list, as they were before.

Note that all UK universities and all NHS Trusts, Hospitals, Boards and GP Practices remain on the list unchanged. The August expansion adds the commercial layer on top of what already existed.

Being on the list is necessary but not sufficient. Your employer being approved does not mean you automatically qualify. You also need to hold a qualifying research grant (see below).

How the UKRI Endorsed Funder pathway works

The pathway has two separate requirements, both of which must be met:

1. Your employer must be on the approved host organisation list

Covered above. Check the GOV.UK list.

2. You must hold a qualifying research grant from an endorsed funder

This is a separate requirement, and a separate list. An endorsed funder is an organisation UKRI recognises as a prestigious research funder: research councils, major medical charities, government bodies, and similar. The grant must meet all of the following:

The list of endorsed funders is here: UKRI endorsed funders list.

If you meet both requirements, endorsement through this pathway takes around two weeks. You do not need to compile a peer review portfolio of publications, citations and recommendation letters. You apply for Global Talent endorsement, provide evidence of the grant and your role, and UKRI makes a fast-track decision.

What if you do not qualify through this pathway?

Most researchers asking about this expansion fall into one of these situations:

If any of these apply, the peer review pathway is the alternative route for researchers and potential research leaders. It takes around five weeks for endorsement and requires a portfolio of published work, recommendation letters from senior academics, and evidence of your standing in your field. It does not require a specific employer or grant.

Not eligible for the fast-track? My research route guide covers the peer review pathway in full: eligibility, evidence, referees and the patterns that lead to rejection.
Get the research guide

Why this matters

The Global Talent Visa endorsed funder pathway has already helped over 12,500 researchers from more than 130 countries build research careers in the UK. Until now, all of them were based at universities or traditional research institutes. The August 2026 expansion reflects a broader shift in where high-value research happens, increasingly in commercial settings, from quantum start-ups to pharmaceutical companies to creative organisations with active research functions.

The government has also signalled further expansion. Companies that want to be added to the list can register their interest with UKRI, and the forthcoming broadening of the Future Technology Research and Innovation (FTRI) scheme will open additional routes for researchers in AI, quantum and engineering biology sectors.

If your employer is not on the current list, it is worth monitoring: the list is updated periodically, and the August 2026 expansion built on an earlier May 2026 addition that covered AIRTO members including IBM.